Edwards Lifesciences Corp shares soared on Monday after the company issued data this weekend showing its less invasive heart valve procedure wasn t inferior to open heart surgery and was superior in some cases Dr Vinod Thourani co principal investigator of the study said results should establish the valve as the new benchmark for the